We are live on ! Find out more
GMAB icon

Genmab
GMAB

133 hedge funds and large institutions have $564M invested in Genmab in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 13

52% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 27

37% more funds holding

Funds holding: 97 → 133 (+36)

11% more capital invested

Capital invested by funds: $511M → $564M (+$53.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.36% less ownership

Funds ownership: 38.78% → 36.42% (-2.4%)

Holders
133
Holders Change
+36
Holders Change %
+37.11%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
50
Increased
41
Reduced
27
Closed
13
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.55M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$5.33M
3
Bank of America
Bank of America
North Carolina
+$4.29M
4
CS
Candriam SCA
Luxembourg
+$4.2M
5
FAM
Fred Alger Management
New York
+$4.08M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$15.6M
2
HM
HealthCor Management
New York
-$14.1M
3
TIP
Torray Investment Partners
Maryland
-$11.8M
4
RG
Redmile Group
California
-$6.81M
5
SIG
Senator Investment Group
New York
-$6.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCB
26
Cutter & Co Brokerage
Missouri
$3.36M -$103K -4,700 -3%
Envestnet Asset Management
27
Envestnet Asset Management
Illinois
$3.08M +$108K +4,952 +4%
Kayne Anderson Rudnick Investment Management
28
Kayne Anderson Rudnick Investment Management
California
$2.84M +$25.5K +1,170 +0.9%
RJA
29
Raymond James & Associates
Florida
$2.67M +$180K +8,233 +7%
Northern Trust
30
Northern Trust
Illinois
$2.66M +$1.2M +55,069 +86%
SSA
31
Schonfeld Strategic Advisors
New York
$2.29M -$3.53M -161,645 -61%
Goldman Sachs
32
Goldman Sachs
New York
$2.23M +$380K +17,420 +21%
Stifel Financial
33
Stifel Financial
Missouri
$2.21M +$36.1K +1,654 +2%
SF
34
Synovus Financial
Georgia
$2.15M -$997K -45,696 -32%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.02M -$19.1K -876 -1%
BIM
36
Bogle Investment Management
Massachusetts
$1.95M +$1.91M +87,471 New
DBT
37
Dubuque Bank & Trust
Iowa
$1.79M +$1.75M +80,380 New
Millennium Management
38
Millennium Management
New York
$1.16M -$5.68M -260,282 -83%
BC
39
Brinker Capital
Pennsylvania
$1.12M +$28.2K +1,291 +3%
CGH
40
Crossmark Global Holdings
Texas
$987K +$965K +44,200 New
SGA
41
Strategic Global Advisors
California
$924K +$903K +41,362 New
Ameriprise
42
Ameriprise
Minnesota
$921K +$9.19K +421 +1%
Balyasny Asset Management
43
Balyasny Asset Management
Illinois
$909K +$888K +40,699 New
Comerica Bank
44
Comerica Bank
Texas
$893K +$20.6K +944 +3%
SEI Investments
45
SEI Investments
Pennsylvania
$846K +$827K +37,888 New
Carson Wealth (CWM LLC)
46
Carson Wealth (CWM LLC)
Nebraska
$823K – – –
First Trust Advisors
47
First Trust Advisors
Illinois
$799K +$781K +35,786 New
FA
48
FDx Advisors
Illinois
$784K -$13.7K -626 -2%
PCM
49
Pentwater Capital Management
Florida
$782K -$32.7K -1,500 -4%
PA
50
Pinnacle Associates
New York
$709K – – –
1
2
3 4 5

GMAB Hedge Fund Activity: Q4 2019 in Review

133 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q4 2019, worth a combined $564M — up 11% from $511M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new GMAB positions and 13 closed out — a net gain of 37 holders — while 41 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $7.55M. The largest seller was Citadel Advisors, cutting an estimated $15.6M.

  • 133 institutional investors held Genmab (GMAB) as of Q4 2019, up from 97 in Q3 2019.
  • Funds reported $564M of Genmab stock for Q4 2019, up 11% quarter-over-quarter.
  • 50 funds opened new Genmab positions in Q4 2019 and 13 closed out, a net change of +37 holders.
  • The largest Genmab buyer in Q4 2019 was BlackRock, an estimated $7.55M added.
  • The largest Genmab seller in Q4 2019 was Citadel Advisors, an estimated $15.6M sold.

Based on aggregated 13F filings for Q4 2019.